Loulergue Pierre, Floret Daniel, Launay Odile
Université Paris Descartes, Sorbonne Paris Cité; INSERM, CIC 1417; Assistance Publique Hôpitaux de Paris (AP-HP), Groupe Hospitalier Cochin Broca Hôtel Dieu, CIC Cochin-Pasteur, 27, rue du faubourg Saint Jacques 75014 Paris, France.
Expert Rev Vaccines. 2015 Jul;14(7):917-22. doi: 10.1586/14760584.2015.1035650. Epub 2015 Apr 25.
France enjoys benefits of a good organization of its healthcare system. National Health Insurance is reimbursing vaccines if they are used according to the national recommendation guidelines. Vaccination is the responsibility of the government, advised by its National Immunization Technical Advisory Group (Comité Technique des vaccinations). But France, like many other countries, faces insufficient involvement from the public in immunization programs and, consequently, numerous outbreaks of vaccine-preventable diseases. The French government launched a 5-year national program for improvement in vaccination policy in 2012 to simplify the guidelines, facilitate access to vaccination, invest in research and evaluate its vaccine policy. The role of the public and healthcare professionals to encourage vaccination is crucial for the future.
法国受益于其良好的医疗体系组织架构。如果疫苗按照国家推荐指南使用,国家健康保险会予以报销。疫苗接种由政府负责,政府会听取其国家免疫技术咨询小组(疫苗接种技术委员会)的建议。但是,法国和许多其他国家一样,面临公众对免疫计划参与不足的问题,因此出现了许多可通过疫苗预防的疾病的疫情爆发。2012年,法国政府启动了一项为期五年的国家计划,以改进疫苗接种政策,简化指南,便利疫苗接种,投资研究并评估其疫苗政策。公众和医疗专业人员在鼓励疫苗接种方面的作用对未来至关重要。